Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey.

Lipids in Health and Disease
Philip BarterRaul D Santos

Abstract

Implementing evidence-based management of dyslipidaemia is a challenge worldwide. To understand physician beliefs and behaviour and identify uncertainties in dyslipidaemia management across four world regions. Web-based survey of 1758 physicians in Japan, Germany, Colombia and the Philippines who were selected randomly from existing databases. Key inclusion criteria were 1) for cardiologists and diabetes/endocrinology specialists: ≥50 dyslipidaemia patients examined in the last month; 2) for specialists in neurology/neurosurgery/stroke medicine: ≥50 dyslipidaemia patients and ≥ 20 patients with a history of ischaemic stroke examined in the last month; and 3) for specialists in nephrology and general medicine: based at centres with ≥20 beds and ≥ 50 dyslipidaemia patients examined in the last month. The self-report survey covered dyslipidaemia management, target low-density lipoprotein cholesterol (LDL-C) levels in different patient groups, and statin safety. All physicians gave voluntary consent and all data were anonymised. Analysis was solely descriptive. The survey highlighted key areas of uncertainty in dyslipidaemia management in the four countries. These related to LDL-C targets in different patient groups, the safety of ...Continue Reading

References

May 6, 2014·The American Journal of Cardiology·Sripal BangaloreUNKNOWN Treating to New Targets Steering Committee and Investigators
Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators
Jun 2, 2016·The Lancet. Diabetes & Endocrinology·Raul D SantosUNKNOWN International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Dec 3, 2016·ASEAN Heart Journal : Official Journal of the ASEAN Federation of Cardiology·Adriel E Guerrero
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
Jul 25, 2017·Annals of Internal Medicine·Steven E Nissen
Aug 3, 2017·Global Heart·Adrianna MurphyDavid Wood
Aug 17, 2017·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN EBBINGHAUS Investigators
May 22, 2018·Journal of Atherosclerosis and Thrombosis·Shizuya YamashitaYuji Matsuzawa
Aug 24, 2018·Journal of Atherosclerosis and Thrombosis·Makoto KinoshitaUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Oct 16, 2018·Journal of Clinical Lipidology·Massimo R MannarinoMatteo Pirro
Nov 8, 2018·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN ODYSSEY OUTCOMES Committees and Investigators
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group
Nov 19, 2019·The New England Journal of Medicine·Pierre AmarencoUNKNOWN Treat Stroke to Target Investigators

❮ Previous
Next ❯

Software Mentioned

PERCRO
DOC

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved